Acorah Software Products - Accounts Production16.3.350truetrue31 January 20241 February 2023falsetrueNo description of principal activity1 February 202431 January 202531 January 202508377050Mrs Nicola Connollyiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure083770502024-01-31083770502025-01-31083770502024-02-012025-01-3108377050frs-bus:PrivateLimitedCompanyLtd2024-02-012025-01-3108377050frs-bus:FilletedAccounts2024-02-012025-01-3108377050frs-bus:Micro-entities2024-02-012025-01-3108377050frs-bus:EntityHasNeverTraded2024-02-012025-01-3108377050frs-bus:AuditExempt-NoAccountantsReport2024-02-012025-01-3108377050frs-bus:Director12024-02-012025-01-31083770502023-01-31083770502024-01-31083770502023-02-012024-01-31
Registered number: 08377050
NAD Medical Device Consultancy Limited
Unaudited Financial Statements
For The Year Ended 31 January 2025
James Walsh Accountant Limited
Association of International Accountants
19 Titan Court Laporte Way
Luton
Beds
LU4 8EF
NAD Medical Device Consultancy Limited
Balance Sheet
As At 31 January 2025
Balance Sheet
Registered number: 08377050
2025
2024
£
£
Current assets
10
10
NET CURRENT ASSETS
10
10
TOTAL ASSETS LESS CURRENT LIABILITIES
10
10
NET ASSETS
10
10
CAPITAL AND RESERVES
10
10
Notes
1.General Information
NAD Medical Device Consultancy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08377050. The registered office is 19 Titan Court, Laporte Way, Luton, Bedfordshire, LU4 8EF.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
--
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.